Expression and role of MHC class I-related chain in myeloma cells

Author： Okamoto M   Inaba T   Yamada N   Uchida R   Fuchida S-I   Okano A   Shimazaki C   Taniwaki M  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.8, Iss.5, 2006-11, pp. : 509-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma

By Wu Jy   Ernstoff Ms   Hill Jm   Cole B   Meehan Kr  

Cytotherapy, Vol. 8, Iss. 2, 2006-05 ,pp. : 141-148

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Multiple Myeloma with Monoclonal Surface Immunoglobulin Expression

By  

Acta Cytologica, Vol. 40, Iss. 2, 2011-09 ,pp. : 358-362

Karger

Access to resources Recommend Favorite

Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation

By Medd P.G.   Chain B.M.  

Seminars in Cell and Developmental Biology, Vol. 11, Iss. 3, 2000-06 ,pp. : 203-210

Academic Press

Access to resources Recommend Favorite

Insufficient ex vivo expansion of Vα24+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells

By Imataki O.   Heike Y.   Makiyama H.   Iizuka A.   Ikarashi Y.   Ishida T.   Wakasugi H.   Takaue Y.  

Cytotherapy, Vol. 10, Iss. 5, 2008-01 ,pp. : 497-506

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells

By Knight Andrea   Mackinnon Stephen   Lowdell Mark W.  

Cytotherapy, Vol. 14, Iss. 9, 2012-10 ,pp. : 1110-1118

Ashgate Publishing Ltd

Access to resources Recommend Favorite